As our results also showed a decrease in Cav-1 as well as integrins αv and β3 (Figure 7), it is possible that artocarpin may at least in part inhibit cancer cell motility via a Cav-1-dependent downregulation of such integrins. The gene discussed is CAV1; the disease is cancer.